Functional Polymorphisms in Folate Metabolism Genes Influence the Risk of Meningioma and Glioma
Open Access
- 1 May 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (5) , 1195-1202
Abstract
Folate metabolism plays an important role in carcinogenesis. To test the hypothesis that polymorphic variation in the folate metabolism genes 5,10-methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) influences the risk of primary brain tumors, we genotyped 1,005 glioma cases, 631 meningioma cases, and 1,101 controls for the MTHFR C677A and A1298C, MTRR A66G, and MTR A2756G variants. MTHFR C677T-A1298C diplotypes were associated with risk of meningioma (P = 0.002) and glioma (P = 0.02); risks were increased with genotypes associated with reduced MTHFR activity. The highest risk of meningioma was associated with heterozygosity for both MTHFR variants [odds ratio (OR), 2.11; 95% confidence interval (95% CI), 1.42-3.12]. The corresponding OR for glioma was 1.23 (95% CI, 0.91-1.66). A significant association between risk of meningioma and homozygosity for MTRR 66G was also observed (OR, 1.41; 95% CI, 1.02-1.94). Our findings provide support for the role of folate metabolism in the development of primary brain tumors. In particular, genotypes associated with increased 5,10-methylenetetrahydrofolate levels are associated with elevated risk. (Cancer Epidemiol Biomarkers Prev 2008;17(5):1195–202)Keywords
This publication has 20 references indexed in Scilit:
- The INTERPHONE study: design, epidemiological methods, and description of the study populationEuropean Journal of Epidemiology, 2007
- Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibilityHuman Molecular Genetics, 2007
- An International Case-Control Study of Glutathione Transferase and Functionally Related Polymorphisms and Risk of Primary Adult Brain TumorsCancer Epidemiology, Biomarkers & Prevention, 2007
- Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant GliomaCancer Research, 2006
- Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomasGenes, Chromosomes and Cancer, 2004
- DNA Methylation and CancerJournal of Clinical Oncology, 2004
- Primary brain tumours as second primary: A novel association between meningioma and colorectal cancerInternational Journal of Cancer, 1999
- A Common Variant in Methionine Synthase Reductase Combined with Low Cobalamin (Vitamin B12) Increases Risk for Spina BifidaMolecular Genetics and Metabolism, 1999
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995